Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Armistead, Paul M ^a,c   Liang, Shoudan ^a   Li, Hua ^a   Lu, Sijie ^a   van Bergen, Cornelis A M ^b   Alatrash, Gheath ^a   St John, Lisa ^a   Hunsucker, Sally A ^c   Sarantopoulos, Stefanie ^c   Falkenburg, J H Frederik ^b   Molldrem, Jeffrey J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MINOR HISTOCOMPATIBILITY ANTIGEN; EPITOPE;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BIOINFORMATICS; CANCER PATIENT; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOMICS; GENOTYPE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MYELOID LEUKEMIA; PEPTIDE MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM; ALLOTRANSPLANTATION; AMINO ACID SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN GENOME; IMMUNOLOGY; KAPLAN MEIER METHOD; LYMPHOCYTE; METABOLISM; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; AMINO ACID SEQUENCE; COHORT STUDIES; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID; LYMPHOCYTES; MALE; MIDDLE AGED; MINOR HISTOCOMPATIBILITY ANTIGENS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79961227889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023217     Document Type: Article

References (34)

1. Falkenburg JH, van de Corput L, Marijt EW, Willemze R, (2003) Minor histocompatibility antigens in human stem cell transplantation. Exp Hematol 31: 743-751.
2. Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, et al. (1994) Identical-twin bone marrow transplants for leukemia. Ann Intern Med 120: 646-652.
3. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, et al. (1996) Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 334: 281-285.
4. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, et al. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75: 555-562.
5. Warren EH, Fujii N, Akatsuka Y, Chaney CN, Mito JK, et al. (2010) Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens. Blood 115: 3869-3878.
6. Mullally A, Ritz J, (2007) Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 109: 1355-1362.
7. Alyea EP, Kim HT, Ho V, Cutler C, Gribben J, et al. (2005) Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. Blood 105: 1810-1814.
8. Barrett AJ, Savani BN, (2006) Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents. Leukemia 20: 1661-1672.
9. Lazarus HM, Rowe JM, (2006) Reduced-intensity conditioning for acute myeloid leukemia: is this strategy correct. Leukemia 20: 1673-1682.
10. Aoudjhane M, Labopin M, Gorin NC, Shimoni A, Ruutu T, et al. (2005) Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Leukemia 19: 2304-2312.
11. Spierings E, Gras S, Reiser JB, Mommaas B, Almekinders M, et al. (2009) Steric hindrance and fast dissociation explain the lack of immunogenicity of the minor histocompatibility HA-1Arg Null allele. Journal of immunology 182: 4809-4816.
12. van Bergen CA, Kester MG, Jedema I, Heemskerk MH, van Luxemburg-Heijs SA, et al. (2007) Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene. Blood 109: 4089-4096.
13. Bleakley M, Otterud BE, Richardt JL, Mollerup AD, Hudecek M, et al. (2010) Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. Blood 115: 4923-4933.
14. Kamei M, Nannya Y, Torikai H, Kawase T, Taura K, et al. (2009) HapMap scanning of novel human minor histocompatibility antigens. Blood 113: 5041-5048.
15. Kawase T, Nannya Y, Torikai H, Yamamoto G, Onizuka M, et al. (2008) Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA. Blood 111: 3286-3294.
16. Van Bergen CA, Rutten CE, Van Der Meijden ED, Van Luxemburg-Heijs SA, Lurvink EG, et al. (2010) High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning. Cancer Res 70: 9073-9083.
17. van Els CA, D'Amaro J, Pool J, Blokland E, Bakker A, et al. (1992) Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics 35: 161-165.
18. den Haan JM, Meadows LM, Wang W, Pool J, Blokland E, et al. (1998) The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 279: 1054-1057.
19. Lin MT, Gooley T, Hansen JA, Tseng LH, Martin EG, et al. (2001) Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation. Blood 98: 3172-3173.
20. Tseng LH, Lin MT, Hansen JA, Gooley T, Pei J, et al. (1999) Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. Blood 94: 2911-2914.
21. McCarroll SA, Bradner JE, Turpeinen H, Volin L, Martin PJ, et al. (2009) Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease. Nat Genet 41: 1341-1344.
22. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
23. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, et al. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
24. Kaplan E, Meier P, (1958) Nonparametric estimator from incomplete observations. J American Statistical Association 53: 457-481.
25. Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, et al. (1998) Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 92: 2303-2314.
26. Peters B, Sette A, (2005) Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 6: 132.
27. Rammensee HG, Bachmann J, Emmerich NN, Bachor OA, Stevanovic S, (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219.
28. Jensen K, Shiels C, Freemont PS, (2001) PML protein isoforms and the RBCC/TRIM motif. Oncogene 20: 7223-7233.
29. Wang Y, Li Y, Qi X, Yuan W, Ai J, et al. (2004) TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of ElK-1 and AP-1. Biochem Biophys Res Commun 323: 9-16.
30. Gack MU, Shin YC, Joo CH, Urano T, Liang C, et al. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446: 916-920.
31. Ozato K, Shin DM, Chang TH, Morse HC, 3rd, (2008) TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 8: 849-860.
32. Rajsbaum R, Stoye JP, O'Garra A, (2008) Type I interferon-dependent and-independent expression of tripartite motif proteins in immune cells. Eur J Immunol 38: 619-630.
33. Li Y, Willer C, Abecasis G, (2009) Genotype Imputation. Annual Review Genomics and Human Genetics 10: 387-406.
34. Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, et al. (2008) NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res 36: W509-512.